Related Experiment Videos
Systemic kappa light-chain deposition. An ultrastructural and immunohistochemical study
The American Journal of Surgical Pathology
|January 1, 1983
Summary
Kappa light-chain deposition disease can affect organs beyond the kidneys, presenting as systemic deposits. This condition is a distinct pathology from amyloidosis and signals underlying plasma cell dyscrasia.
Area of Science:
- Pathology
- Immunology
- Oncology
Background:
- Plasma cell dyscrasias can manifest with light chain deposition, typically affecting the kidneys.
- Distinguishing light chain deposition from amyloidosis is crucial for accurate diagnosis and treatment.
Observation:
- A 55-year-old patient presented with respiratory insufficiency and hepatomegaly, exhibiting non-amyloidotic PAS-positive deposits in lung and liver biopsies.
- Immunohistochemistry confirmed these deposits were composed of kappa light-chain immunoglobulin.
- Electron microscopy revealed granular and fibrillar electron-dense material, differing from amyloid ultrastructure.
Findings:
- Kappa light-chain deposition is not exclusive to renal pathology and can present systemically.
- These deposits can be differentiated from amyloidosis through immunochemical, tinctorial, and ultrastructural analyses.
- Systemic light chain deposition may be an early indicator of plasma cell dyscrasia.
Implications:
- This case expands the known organ involvement of kappa light-chain deposition disease.
- The findings highlight the importance of considering non-renal light chain deposition in diagnosing plasma cell dyscrasias.
- Accurate differentiation from amyloidosis is critical for appropriate patient management and therapeutic strategies.